Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Buprenorphine trialled for depression in people with dementia

The potential role of transdermal buprenorphine as a treatment for depression in nursing home residents with dementia has been investigated in Norway (Drugs...Read more

CQC concerns about sexual safety on mental health wards

Sexual incidents accounted for 1120 of the 60 000 incidents reported on NHS mental health wards in England between April and June 2017, the Care Quality...Read more

Better physical health support for people with mental health conditions

Fifty UK charities and health organisations have joined forces to promote their Charter for Equal Health through a new initiative, Equally Well UK...Read more

Community pharmacists to promote wellbeing

NICE has published a guideline setting out how community pharmacists can help to improve health and wellbeing in the community. Guideline NG102 recommends...Read more

Fewer suicides among UK men

The rate of registered suicides among men in the UK in 2017 was the lowest since the current monitoring programme began in 1981, Government data show...Read more

Featured Articles

Genetic investigation in dementia: new interpretive challenges
Genetic testing is increasingly used in the assessment and investigation of individuals with dementia and cognitive impairment. Next generation sequencing dementia panels allow simultaneous parallel examination of multiple genes. But with this increased diagnostic power comes also the possibility of incidental findings, of identifying sequence variants which are benign rather than pathogenic. Dr Larner and colleagues discuss two such cases.
Click here to view

Screening for depression in patients with cognitive impairment: a local audit
Depression is highly prevalent in cognitive impairment and is considered one of the most common comorbid conditions in dementia. Despite this, underlying depressive symptoms can easily be missed by health care providers, mainly due to lack of awareness and lack of routine screening for depressive symptoms. Here, the authors examine the results of their local audit in Oxleas NHS Foundation Trust screening for depression in those diagnosed with dementia and discuss what their recommendations are for improving this aspect of clinical care in the future.
Click here to view

Beta-amyloid PET imaging for Alzheimer’s dementia diagnosis
Beta-amyloid (Aß) positron emission tomography (PET) imaging is utilised as an important diagnostic tool in NHS dementia research in the UK and worldwide. Aß PET imaging is now licensed for clinical use in the UK. This review explores the potential for the use of Aß PET imaging in clinical practice highlighting recent evidence base followed by a discussion of potential benefits in the context of important clinical and practical considerations.
Click here to view

Web design and marketing agency Leamington Spa